The safety and efficacy of the 308-nm excimer laser for pigment correction of hypopigmented scars and striae alba

被引:61
作者
Alexiades-Armenakas, MR [1 ]
Bernstein, LJ [1 ]
Friedman, PM [1 ]
Geronemus, RG [1 ]
机构
[1] Laser & Skin Surg Ctr New York, New York, NY USA
关键词
D O I
10.1001/archderm.140.8.955
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To assess the safety and efficacy of the 308-nm excimer laser in pigment correction of hypopigmented scars and striae alba. Design: Institutional review board-approved randomized controlled trial. Setting: Private research center. Patients: Volunteer sample of 31 adult subjects with hypopigmented scars or striae alba distributed on the face, torso, or extremities. Interventions: Lesions were randomized to receive treatment or not, with site-matched normal control areas. Treatments were initiated with a minimal erythema dose minus 50 mJ/cm(2) to affected areas. Subsequent treatments were performed biweekly until 50% to 75% pigment correction, then every 2 weeks thereafter until a maximum of 10 treatments, 75% increase in colorimetric measurements, or 100% visual pigment correction. Main Outcome Measures: Pigment correction by visual and colorimetric assessments compared with untreated control lesions and site-matched normal skin before each treatment and at 1-, 2-, 4-, and 6-month follow-up intervals. Occurrence of erythema, blistering, dyspigmentation, or other adverse effects was monitored. Results: The percentage pigment correction by both assessments increased in direct proportion to the number of treatments. The mean percentage pigment correction by visual assessment relative to control of 61% (95% confidence interval [CI], 55%-67%) for scars and 68% (95% CI, 62%-74%) for striae was achieved after 9 treatments. The mean percentage pigmentation by colorimetric measurements relative to control of 101% (95% CI, 99%-103%) for scars and 102% (95% CI, 99%-104%) for striae was achieved after 9 treatments. Both sets of values gradually declined toward baseline levels during the 6-month follow-up. No blistering or dyspigmentation occurred. Conclusions: Therapy with the 308-nm excimer laser is safe and effective in pigment correction of hypopigmented scars and striae alba. Mean final pigment correction rates relative to control sites of approximately 60% to 70% by visual assessment and 100% by colorimetric analysis were observed after 9 treatments administered biweekly. Maintenance treatment every 1 to 4 months is required to sustain the cosmetic benefit.
引用
收藏
页码:955 / 960
页数:6
相关论文
共 34 条
  • [1] Açikel C, 2000, PLAST RECONSTR SURG, V105, P1973
  • [2] ALEXIADESARMENA.MR, 2003, 30 ANN CLIN SCI M AM
  • [3] Alster TS, 1997, DERMATOL CLIN, V15, P419, DOI 10.1016/S0733-8635(05)70451-4
  • [4] Treatment of scars: A review
    Alster, TS
    West, TB
    [J]. ANNALS OF PLASTIC SURGERY, 1997, 39 (04) : 418 - 432
  • [5] Treatment of vitiligo with the 308-nm xenon chloride excimer laser
    Baltás, E
    Csoma, Z
    [J]. ARCHIVES OF DERMATOLOGY, 2002, 138 (12) : 1619 - 1620
  • [7] Skin color measurements:: comparison between three instruments:: the Chromameter®, the DermaSpectrometer® and the Mexameter®
    Clarys, P
    Alewaeters, K
    Lambrecht, R
    Barel, AO
    [J]. SKIN RESEARCH AND TECHNOLOGY, 2000, 6 (04) : 230 - 238
  • [8] p53 mutations as a marker of skin cancer risk: comparison of UVA and UVB effects
    de Gruijl, FR
    [J]. EXPERIMENTAL DERMATOLOGY, 2002, 11 : 37 - 39
  • [9] ELDER DE, 1995, CANCER, V75, P245, DOI 10.1002/1097-0142(19950101)75:1+<245::AID-CNCR2820751310>3.0.CO
  • [10] 2-7